EOLS
Price
$9.27
Change
+$0.06 (+0.65%)
Updated
Jul 3 closing price
Capitalization
846.82M
26 days until earnings call
RDHL
Price
$2.00
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
15.74M
41 days until earnings call
Interact to see
Advertisement

EOLS vs RDHL

Header iconEOLS vs RDHL Comparison
Open Charts EOLS vs RDHLBanner chart's image
Evolus
Price$9.27
Change+$0.06 (+0.65%)
Volume$424.23K
Capitalization846.82M
Redhill Biopharma
Price$2.00
Change-$0.00 (-0.00%)
Volume$574
Capitalization15.74M
EOLS vs RDHL Comparison Chart in %
Loading...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EOLS vs. RDHL commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EOLS is a Hold and RDHL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (EOLS: $9.27 vs. RDHL: $2.03)
Brand notoriety: EOLS and RDHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EOLS: 41% vs. RDHL: 11%
Market capitalization -- EOLS: $846.82M vs. RDHL: $15.74M
EOLS [@Pharmaceuticals: Other] is valued at $846.82M. RDHL’s [@Pharmaceuticals: Other] market capitalization is $15.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EOLS’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • EOLS’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, RDHL is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EOLS’s TA Score shows that 3 TA indicator(s) are bullish while RDHL’s TA Score has 5 bullish TA indicator(s).

  • EOLS’s TA Score: 3 bullish, 3 bearish.
  • RDHL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RDHL is a better buy in the short-term than EOLS.

Price Growth

EOLS (@Pharmaceuticals: Other) experienced а -0.43% price change this week, while RDHL (@Pharmaceuticals: Other) price change was +11.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

EOLS is expected to report earnings on Jul 30, 2025.

RDHL is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EOLS($847M) has a higher market cap than RDHL($15.7M). EOLS YTD gains are higher at: -16.033 vs. RDHL (-67.311). RDHL has higher annual earnings (EBITDA): 52.8M vs. EOLS (-41.81M). EOLS has more cash in the bank: 62.8M vs. RDHL (7.01M). RDHL has less debt than EOLS: RDHL (2.28M) vs EOLS (127M). EOLS has higher revenues than RDHL: EOLS (202M) vs RDHL (35.7M).
EOLSRDHLEOLS / RDHL
Capitalization847M15.7M5,395%
EBITDA-41.81M52.8M-79%
Gain YTD-16.033-67.31124%
P/E RatioN/AN/A-
Revenue202M35.7M566%
Total Cash62.8M7.01M895%
Total Debt127M2.28M5,560%
FUNDAMENTALS RATINGS
EOLS vs RDHL: Fundamental Ratings
EOLS
RDHL
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8465
P/E GROWTH RATING
1..100
10083
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDHL's Valuation (84) in the Biotechnology industry is in the same range as EOLS (87) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

EOLS's Profit vs Risk Rating (75) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

EOLS's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as RDHL (100) in the Biotechnology industry. This means that EOLS’s stock grew similarly to RDHL’s over the last 12 months.

RDHL's Price Growth Rating (65) in the Biotechnology industry is in the same range as EOLS (84) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

RDHL's P/E Growth Rating (83) in the Biotechnology industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that RDHL’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EOLSRDHL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
80%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKS5.130.38
+8.00%
ONE Group Hospitality (The)
AZTA33.230.38
+1.16%
Azenta
ERNA2.000.02
+1.01%
Ernexa Therapeutics Inc
BRO108.700.89
+0.83%
Brown & Brown
EMBC10.320.07
+0.68%
Embecta Corp

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with AMRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+0.65%
AMRX - EOLS
33%
Loosely correlated
+0.60%
ALKS - EOLS
31%
Poorly correlated
-0.52%
NBIX - EOLS
30%
Poorly correlated
-0.22%
AQST - EOLS
30%
Poorly correlated
+1.09%
PRGO - EOLS
28%
Poorly correlated
-0.22%
More

RDHL and

Correlation & Price change

A.I.dvisor tells us that RDHL and ACET have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
+1.50%
ACET - RDHL
27%
Poorly correlated
-1.14%
EOLS - RDHL
27%
Poorly correlated
+0.65%
SNOA - RDHL
23%
Poorly correlated
+1.71%
DVAX - RDHL
23%
Poorly correlated
+1.08%
TEVA - RDHL
22%
Poorly correlated
-0.23%
More